Recurrent Temporomandibular Joint Dislocation Treated with Botulinum Toxin: Report of 3 Cases

Journal of Oral and Maxillofacial Surgery

Volumn 62, Issue 2, 2004, Pages 244-246

  Martínez Pérez, Dolores ^a   García Ruiz Espiga, Pedro ^b  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; DRUG EFFICACY; ELECTROMYOGRAPHY; FEMALE; HUMAN; PALATOPHARYNGEAL INCOMPETENCE; RECURRENT DISLOCATION; RECURRENT TEMPOROMANDIBULAR JOINT DISLOCATION; TECHNIQUE; TEMPOROMANDIBULAR JOINT DISORDER;

EID: 19244368008     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joms.2003.04.014     Document Type: Article

References (30)

1. Undt G, Weichselbraun A, Wagner A, et al: Recurrent mandibular dislocation under neuroleptic drug therapy treated by bilateral eminectomy. J Craniomaxillofac Surg 20:217, 1996
2. Raman U, Samray T: Unusual dislocation of the temporomandibular joints. A case report. Int J Oral Maxillofac Surg 20:217, 1991
3. Blitzer A, Sulica L: Botulinum toxin: Basic science and clinical uses in otolaryngology. Laryngoscope 111:218, 2001
4. Moore AP, Wood GD: Medical treatment of recurrent temporomandibular dislocation using botulinum toxin A. Br Dent J 183:415, 1997
5. Gilles R, Magistris MR, Hugentobler M, et al: Traitement de la luxation temporo-mandibulaire récidvante par toxine botulique. Rev Stomatol Chir Maxillofac 101:189, 2000
6. Daelen B, Thorwirth V, Koch A: Treatment of recurrent dislocation of the temporomandibular joint with type A botulinum toxin. Int J Oral Maxillofac Surg 26:458, 1997
7. Hambleton P, Moore AP: Botulinum neurotoxins: Origin, structure, molecular actions and antibodies, in Moore AP (ed): Handbook of Botulinim Toxin Treatment. Oxford, England, Blackwell Scientific, 1995, pp 16-27
8. Brin MF: Botulinum toxin therapy: Basic sciences and overview of other therapeutic applications, in Blitzer A, Binder WJ, Boyd JB, et al (eds): Management of Facial Lines and Wrinkles. Philadelphia, PA, Lippincott Williams and Wilkins, 1999, pp 279-302
9. Brin MF, Fahn S, Moskowitz C, et al: Localized injections of botulinum toxin for the treatment of focal dystonias and hemifacial spasm. Mov Disord 2:237, 1987
10. Brin M, Blitzer A, Fahn S, et al: Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia. Laryngoscope 98:193, 1988
11. Gelb D, Lowenstein D, Aminoff M: Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis. Neurology 39:80, 1989
12. Greene P, Kang U, Fhan S, et al: Double blind placebo controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis. Neurology 40:1213, 1990
13. Pidcock FS, Wise JM, Christensen JR: Treatment of severe post-traumatic bruxism with botulinum toxin A: Case report. J Oral Maxillofac Surg 60:115, 2002
14. Lees AJ, Turjanski N, Rivest J, et al: Treatment of cervical dystonia, hand spasm and laryngeal dystonia with botulinum toxin. J Neurol 239:1, 1992
15. Garcia Ruiz PJ, Cenjor Español C, Sanchez Bernardos V, et al: Botulinum toxin treatment for spasmodic dysphonia: Percutaneous versus transoral approach. Clin Neuropharmacol 21:196, 1998
16. Koman LA, Mooney JD, Smith BP, et al: Management of cerebral palsy with botulinum-A toxin. Preliminary investigation. J Pediatr Orthop 13:489, 1993
17. Koman LA, Mooney JD, Mulvaney T, et al: Further evaluation of botulinum A toxin (Botox) in the management of cerebral palsy. Dev Med Child Neurol 35:29, 1993 (suppl 9)
18. Calderón Gonzalez R, Calderón Sepúlveda R, Rincón Reyes M, et al: Botulinum toxin A in management of cerebral palsy. Pediatr Neurol 10:284, 1994
19. Koman LA, Mooney JF, Smith BP: Botulinum toxin: Potential role in the management of cerebral palsy during childhood, in Jankovic J, Hallet M (eds): Therapy with Botulinum Toxin. New York, NY, Marcel Dekker, 1994, pp 511-522
20. Cosgrove AP, Corry IS, Graham HK: Botulinum toxin in the management of the lower limb in cerebral palsy. Dev Med Child Neurol 36:386, 1994
21. Koman LA, Mooney JF, Smith BP, et al: Management of spasticity in cerebral palsy with botulinum A toxin: Report of a preliminary, randomized, double blind trial. J Pediatr Orthop 14:299, 1994
22. Boyd R, Graham HK: Botulinum toxin A in the management of children with cerebral palsy: indications and outcome. Eur J Neurol 4:15, 1997 (suppl 2)
23. Blitzer A, Brin M, Greene PE, et al: Botulinum toxin injection for the treatment of orofacial dystonia. Ann Otol Rhinol Laryngol 98:93, 1989
24. Brin MF, Blitzer A, Herman S, et al: Orofaciomandibular and lingual dystonia, in Moore AP (eds): Handbook of Botulinim Toxin Treatment. Oxford, England, Blackwell Scientific, 1995, pp 151-163
25. Brin MF, Blitzer A, Herman S, et al: Oromandibular dystonia: Treatment of 96 patients with botulinum toxin, in Jankovic J, Hallett M (eds): Therapy With Botulinum Toxin. New York, NY, Marcel Dekker, 1994, pp 429-435
26. Binder VO, Blitzer A, Brin MF: Treatment of hyperfunctional lines of the face with botulinum toxin A. Dermatol Surg 24:1198, 1998
27. Fulton JE: Botulinum toxin: The Newport Beach experience. Dermatol Surg 24:1219, 1998
28. Carruthers JD, Carruthers JA: Treatment of glabellar frown lines with C Botulinum-A exotoxin. J Dermatol Surg Oncol 18:17, 1992
29. Klein AW, Wexler P, Carruthers A, et al: Treatment of facial furrows and rhytides. Dermatol Clin 15:595, 1997
30. Carruthers A, Kiene K, Carruthers J: Botulinum toxin A exotoxin use in clinical dermatology. J Am Acad Dermatol 34:788, 1996